{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:13:56Z","timestamp":1790720036034,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.spen.2021.100876","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T12:14:56Z","timestamp":1612959296000},"page":"100876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Recent Advancements in the Diagnosis and Treatment of Leukodystrophies"],"prefix":"10.1016","volume":"37","author":[{"given":"Allison M.","family":"Bradbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margie A.","family":"Ream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2021.100876_bib0001","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00401-017-1739-1","article-title":"Leukodystrophies: A proposed classification system based on pathological changes and pathogenetic mechanisms","volume":"134","author":"van der Knaap","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.spen.2021.100876_bib0002","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymgme.2015.01.006","article-title":"Case definition and classification of leukodystrophies and leukoencephalopathies","volume":"114","author":"Vanderver","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100876_bib0003","article-title":"Expanded phenotypic definition identifies hundreds of potential causative genes for leukodystrophies and leukoencephalopathies","volume":"7","author":"Urbik","year":"2020","journal-title":"Child Neurol Open"},{"key":"10.1016\/j.spen.2021.100876_bib0004","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.spen.2012.10.001","article-title":"Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders","volume":"19","author":"Vanderver","year":"2012","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0005","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.0b013e3181eee46b","article-title":"The burden of inherited leukodystrophies in children","volume":"75","author":"Bonkowsky","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100876_bib0006","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pediatrneurol.2020.06.005","article-title":"Elevated leukodystrophy incidence predicted from genomics databases","volume":"111","author":"Soderholm","year":"2020","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0007","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s40615-020-00722-w","article-title":"Racial\/ethnic and insurance status disparities in distance traveled to access children's hospital care for severe illness: The case of children with leukodystrophies","volume":"7","author":"Grineski","year":"2020","journal-title":"J Racial Ethn Health Disparities"},{"key":"10.1016\/j.spen.2021.100876_bib0008","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1474-4422(19)30143-7","article-title":"Diagnosis, prognosis, and treatment of leukodystrophies","volume":"18","author":"van der Knaap","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0009","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0036-1588020","article-title":"Update on leukodystrophies: A historical perspective and adapted definition","volume":"47","author":"Kevelam","year":"2016","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.spen.2021.100876_bib0010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ana.24650","article-title":"Whole exome sequencing in patients with white matter abnormalities","volume":"79","author":"Vanderver","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0011","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/acn3.50957","article-title":"Genome sequencing in persistently unsolved white matter disorders","volume":"7","author":"Helman","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0012","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41431-018-0114-6","article-title":"Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing","volume":"26","author":"Costain","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.spen.2021.100876_bib0013","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41525-020-00144-x","article-title":"A three-year follow-up study evaluating clinical utility of exome sequencing and diagnostic potential of reanalysis","volume":"5","author":"Fung","year":"2020","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.spen.2021.100876_bib0014","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41436-020-0764-y","article-title":"The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease","volume":"22","author":"Guenzel","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2021.100876_bib0015","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41436-018-0371-3","article-title":"Development of a newborn screening tool based on bivariate normal limits: Using psychosine and galactocerebrosidase determination on dried blood spots to predict Krabbe disease","volume":"21","author":"Langan","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.spen.2021.100876_bib0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2017.05.015","article-title":"Psychosine, a marker of Krabbe phenotype and treatment effect","volume":"121","author":"Escolar","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100876_bib0017","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ymgme.2019.11.426","article-title":"ScreenPlus: A comprehensive, dynamic, multi-disorder newborn screening pilot program","volume":"129","author":"Wasserstein","year":"2020","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100876_bib0018","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0883073820946154","article-title":"Practical approaches and knowledge gaps in the care for children with leukodystrophies","volume":"36","author":"Keller","year":"2021","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2017.08.006","article-title":"Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies","volume":"122","author":"Adang","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100876_bib0020","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1007\/s00415-020-09889-y","article-title":"Epilepsy in children with leukodystrophies","volume":"267","author":"Zhang","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0021","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0b013e3182309f72","article-title":"GFAP mutations, age at onset, and clinical subtypes in Alexander disease","volume":"77","author":"Prust","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100876_bib0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/pmt.14.45","article-title":"Pediatric pain management in palliative care","volume":"5","author":"Downing","year":"2015","journal-title":"Pain Manag"},{"key":"10.1016\/j.spen.2021.100876_bib0023","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/096368979500400409","article-title":"Microglia: The effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases","volume":"4","author":"Krivit","year":"1995","journal-title":"Cell Transplant"},{"key":"10.1016\/j.spen.2021.100876_bib0024","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nm1201-1356","article-title":"Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment","volume":"7","author":"Priller","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.spen.2021.100876_bib0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41409-017-0015-2","article-title":"Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: A suitable choice in an urgent situation","volume":"53","author":"Fernandes","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.spen.2021.100876_bib0026","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.bbmt.2019.09.003","article-title":"Hematopoietic stem cell transplantation to treat leukodystrophies: Clinical practice guidelines from the Hunter's Hope leukodystrophy care network","volume":"25","author":"Page","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.spen.2021.100876_bib0027","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/bloodadvances.2020001554","article-title":"Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant","volume":"4","author":"Sharma","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.spen.2021.100876_bib0028","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/pbc.24126","article-title":"Levetiracetam for busulfan-induced seizure prophylaxis in children undergoing hematopoietic stem cell transplantation","volume":"59","author":"Soni","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.spen.2021.100876_bib0029","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13023-015-0313-y","article-title":"Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: The largest single-institution cohort report","volume":"10","author":"Boucher","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100876_bib0030","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood-2016-03-708479","article-title":"Efficacy of hematopoietic cell transplantation in metachromatic leukodystrophy: The Dutch experience","volume":"127","author":"van Rappard","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.spen.2021.100876_bib0031","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2021.100876_bib0032","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbmt.2018.06.020","article-title":"Long-Term functional outcomes after hematopoietic stem cell transplant for early infantile Krabbe disease","volume":"24","author":"Allewelt","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.spen.2021.100876_bib0033","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbmt.2018.09.036","article-title":"Survival and functional outcomes in boys with cerebral adrenoleukodystrophy with and without hematopoietic stem cell transplantation","volume":"25","author":"Raymond","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.spen.2021.100876_bib0034","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10545-014-9797-1","article-title":"Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: A retrospective study","volume":"38","author":"van Geel","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.spen.2021.100876_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1212\/01.wnl.0000230156.01228.33","article-title":"Peripheral neuropathy in Krabbe disease: Effect of hematopoietic stem cell transplantation","volume":"67","author":"Siddiqi","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.spen.2021.100876_bib0036","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13023-018-0766-x","article-title":"Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease","volume":"13","author":"Kwon","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.spen.2021.100876_bib0037","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","article-title":"Newborn screening for X-linked adrenoleukodystrophy in New York State: Diagnostic protocol, surveillance protocol and treatment guidelines","volume":"114","author":"Vogel","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.spen.2021.100876_bib0038","doi-asserted-by":"crossref","first-page":"e86667","DOI":"10.1172\/jci.insight.86667","article-title":"A cord blood monocyte-derived cell therapy product accelerates brain remyelination","volume":"1","author":"Saha","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.spen.2021.100876_bib0039","doi-asserted-by":"crossref","first-page":"155ra136","DOI":"10.1126\/scitranslmed.3004371","article-title":"Human neural stem cells induce functional myelination in mice with severe dysmyelination","volume":"4","author":"Uchida","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.spen.2021.100876_bib0040","doi-asserted-by":"crossref","first-page":"14720","DOI":"10.1073\/pnas.97.26.14720","article-title":"Direct isolation of human central nervous system stem cells","volume":"97","author":"Uchida","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.spen.2021.100876_bib0041","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13287-019-1374-y","article-title":"Temporal and partial inhibition of GLI1 in neural stem cells (NSCs) results in the early maturation of NSC derived oligodendrocytes in vitro","volume":"10","author":"Namchaiw","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.spen.2021.100876_bib0042","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.stemcr.2019.07.002","article-title":"Long-term safety, immunologic response, and imaging outcomes following neural stem cell transplantation for pelizaeus-merzbacher disease","volume":"13","author":"Gupta","year":"2019","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.spen.2021.100876_bib0043","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJMoa1700554","article-title":"Hematopoietic stem-cell gene therapy for cerebral adrenoleukodystrophy","volume":"377","author":"Eichler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.spen.2021.100876_bib0044","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(16)30374-9","article-title":"Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: An ad-hoc analysis of a non-randomised, open-label, phase 1\/2 trial","volume":"388","author":"Sessa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2021.100876_bib0045","first-page":"32","article-title":"Immune blockade in CNS gene therapy improves safety and clinical outcome","volume":"26","author":"Corti","year":"2018","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.spen.2021.100876_bib0046","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s13311-020-00865-y","article-title":"Cerebellar astrocyte transduction as gene therapy for megalencephalic leukoencephalopathy","volume":"17","author":"Sanchez","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.spen.2021.100876_bib0047","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1172\/JCI133953","article-title":"Krabbe disease successfully treated via monotherapy of intrathecal gene therapy","volume":"130","author":"Bradbury","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.spen.2021.100876_bib0048","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/hum.2019.008","article-title":"An engineered galactosylceramidase construct improves AAV gene therapy for krabbe disease in twitcher mice","volume":"30","author":"Pan","year":"2019","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.spen.2021.100876_bib0049","doi-asserted-by":"crossref","first-page":"105","DOI":"10.34172\/bi.2020.13","article-title":"Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease","volume":"10","author":"Rafi","year":"2020","journal-title":"Bioimpacts"},{"key":"10.1016\/j.spen.2021.100876_bib0050","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/mt.2015.6","article-title":"Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy","volume":"23","author":"Gong","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.spen.2021.100876_bib0051","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/gt.2014.17","article-title":"Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector","volume":"21","author":"Miyake","year":"2014","journal-title":"Gene Ther"},{"key":"10.1016\/j.spen.2021.100876_bib0052","doi-asserted-by":"crossref","first-page":"e90807","DOI":"10.1172\/jci.insight.90807","article-title":"Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease","volume":"2","author":"Gessler","year":"2017","journal-title":"JCI Insight"},{"issue":"4S1","key":"10.1016\/j.spen.2021.100876_bib0053","first-page":"411","article-title":"Preclinical gene replacement therapy with a new scAAV9\/SUMF1 viral vector for the treatment of multiple sulfatase deficiency","volume":"28","author":"Presa","year":"2020","journal-title":"Mol Therap"},{"key":"10.1016\/j.spen.2021.100876_bib0054","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ana.25674","article-title":"Antisense oligonucleotide reverses leukodystrophy in canavan disease mice","volume":"87","author":"Hull","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41586-020-2494-3","article-title":"Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease","volume":"585","author":"Elitt","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.spen.2021.100876_bib0056","doi-asserted-by":"crossref","first-page":"e125052","DOI":"10.1172\/jci.insight.125052","article-title":"Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA","volume":"4","author":"Li","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.spen.2021.100876_bib0057","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/acn3.51015","article-title":"Vorinostat in the acute neuroinflammatory form of X-linked adrenoleukodystrophy","volume":"7","author":"Zierfuss","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.spen.2021.100876_bib0058","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2020.07.002","article-title":"Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1\/2 clinical trial","volume":"131","author":"Dali","year":"2020","journal-title":"Mol Genet Metab"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:38:18Z","timestamp":1761028698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909121000048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":58,"alternative-id":["S1071909121000048"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2021.100876","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advancements in the Diagnosis and Treatment of Leukodystrophies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2021.100876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100876"}}